Compare CE & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CE | BLCO |
|---|---|---|
| Founded | 1918 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.0B |
| IPO Year | 2004 | 2022 |
| Metric | CE | BLCO |
|---|---|---|
| Price | $64.05 | $16.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $61.69 | $18.55 |
| AVG Volume (30 Days) | ★ 2.6M | 408.3K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 23.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,544,000,000.00 | $5,101,000,000.00 |
| Revenue This Year | $1.27 | $8.63 |
| Revenue Next Year | $3.39 | $5.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $35.13 | $10.45 |
| 52 Week High | $67.82 | $18.92 |
| Indicator | CE | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 62.04 | 49.94 |
| Support Level | $37.64 | $16.35 |
| Resistance Level | N/A | $16.81 |
| Average True Range (ATR) | 3.14 | 0.52 |
| MACD | 0.42 | 0.06 |
| Stochastic Oscillator | 70.39 | 77.14 |
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.